FDA Staff Not Convinced Of Clovis Cancer Drug Safety
The U.S. Food and Drug Administration aired concerns Friday about the safety of Clovis Oncology Inc.'s lung cancer drug rociletinib and about whether the drug is more effective than drugs currently...To view the full article, register now.
Already a subscriber? Click here to view full article